First patient receives age-reversal therapy in historic human trial Boston-based Life Biosciences has dosed the first participant with ER-100, an experimental therapy designed to reverse aspects of cellular aging and treat vision loss
分享
25 articles on page 1
20 九月
青春、长寿与身体更新的问题。老年学领域的研究，关于寿命的新科学观点。